Pfizer asked the FDA to authorize its Covid-19 booster dose for children 5 to 11 years old. The agency is expected to take a couple of weeks to conduct its review, a person familiar with the matter said. on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
